In March 2018, the Office of the United States Trade Representative (USTR) published its 2018 National Trade Estimates Report on Foreign Trade Barriers (NTE). Every year, the USTR is mandated to “submit to the President,the Senate Finance Committee, and appropriate committees in the House of Representatives, an annual report on significant foreign trade barriers. The […]
On 21 February 2018, the European Commission published a report on the “protection and enforcement of intellectual property rights in third countries”. The main objective of the report “is to identify third countries in which the state of IPR protection and enforcement gives rise to the greatest level of concern and thereby to establish an
On Tuesday, 6 March 2018, Cristina Pucarinho, the Deputy Permanent Representative of Portugal to the United Nations made the following intervention at a UN briefing on Promoting Innovation and Access to Health Technologies in the Context of the Agenda 2030 in New York. Portugal’s intervention on transparency in New York echoed the statement Portugal delivered
Sign on to support our Crown use request to the UK government for T-DM1 Loading…
Support Letter for Access to T-DM1 in the UK Read More »
Press Release: Coalition for Affordable T-DM1 Asks the Government to Employ Crown Use Authority to Lower Price of Expensive Cancer Drug CONTACT: Diarmaid McDonald email: accessdiarmaid@gmail.com +44.7894.4557.81 Susannah Markandya email: s.markandya@gmail.com +44.7811.9573.12 Zack Struver email: zack.struver@keionline.org Cell: +1.914.582.1428 Office: +1.202.332.2670 (between 2:00 PM and 10:00 PM BST) London, 1 October 2015 – The Coalition
Press Release Regarding Access to T-DM1 in the United Kingdom Read More »
Portugal delivered the following statement at the 70th World Health Assembly on agenda item, 13.3 – Global shortage of, and access to medicines and vaccines. In relation to the Report of the United Nations High-Level Panel on Access to Medicines (UNHLP), the delegation of Portugal quoted the intervention delivered by the Portuguese Minister of Health,
On 2nd May 2017, the European Commission responded to KEI Europe’s letter (31st March 2017) requesting the European Union to “support a WHO resolution on cancer that would provide the organization a mandate to conduct a feasibility study of creating a multi-country push and pull fund for cancer R&D predicated upon the principle of the
On 8 March 2017, the Permanent Representative of Portugal, Ambassador Pedro Nuno Bártolo, made a powerful intervention at the Human Rights Council’s panel discussion on access to medicines. Portugal stressed that access to medicines is a fundamental element of the right to health and highlighted how the high prices of hepatitis C and cancer medicines
8 March 2017 – Statement of Portugal – HRC 34 – Panel on Access to Medicines Read More »
On 8 March 2017, the European Union (EU) delivered the following statement to the Human Rights Council’s panel discussion on Access to Medicines. As the Human Right Council imposed a strict two minute limit on interventions, the EU was not able to raise the following two questions contained at the end of its intervention. I
8 March 2017 – Statement of the European Union – HRC 34 – Panel on Access to Medicines Read More »
On 2 February 2017, MEP Lola Sánchez Caldentey (Podemos, Spain) tabled a series of written questions to the European Commission on the positions taken by the European Union at the World Intellectual Property Organization on 14 December 2016 in relation to the United Nations High-Level Panel on Access to Medicines (UN HLP) At the December
